is mrd testing routinely recommended for myeloma patients?
Published 5 years ago • 279 plays • Length 5:15Download video MP4
Download video MP3
Similar videos
-
5:49
is minimal residual disease (mrd) testing routinely recommended?
-
4:10
how does minimal residual disease (mrd) testing affect treatment decisions?
-
5:05
should minimal residual disease (mrd) testing be routinely performed?
-
3:26
how valuable is minimal residual disease testing for myeloma patients?
-
3:44
what is mrd, or minimal residual disease?
-
4:01
if a myeloma patient has mrd-negative status, does that mean that patient is cured?
-
2:28
what is minimal residual disease (mrd) and how can it help speed up new myeloma drug approvals?
-
3:21
is there a new highly sensitive blood test to detect minimal residual disease?
-
1:36
how is minimal residual disease (mrd) testing used in myeloma care?
-
3:18
what does it mean when a myeloma patient is mrd negative?
-
1:11:05
the utility of mrd testing for myeloma patient treatment and outcomes
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies
-
1:12:05
a practical approach to mrd: testing with clonoseq
-
3:14
if the mrd test is negative, is that always a good predictor of a longer remission?
-
2:31
determining the optimal threshold to test mrd in multiple myeloma
-
3:03
if you have myeloma, should you undergo tests for dna sequencing?
-
8:52
mrd testing for myeloma what is it, why should it be used, and why
-
0:55
sustained mrd negativity in multiple myeloma
-
2:57
when is the optimal time to measure minimal residual disease (mrd) in myeloma patients?